Processing data from genotyping chips

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The 23Andme, Inc. patent solves the following problem:

The instructions for making cells in the human body is encoded in deoxyribonucleic acid (DNA). DNA is a long, ladder-shaped molecule, each equivalent to climb up on a pair of interlocking units, called bases, appointed by the four letters of DNA AlphaBeta, T, G and C. a always pairs or chains with T, and G always pairs or chains with C. the order of these four letters in one DNA called human genome.

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 8645343 B2 deals with Processing data from genotyping chips.
Processing genetic data disclosed, including: receiving two or more gene sets of data for an individual from the source of one or more of the gene data; combining the genetic data sets from one or more genetic data sources, including the recognition of a copy SNP among the genetic data set and determine the one or more data values ​​stored for duplicate SNP; and storing a set of Merged genetic data for the individual.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

De-identification and sharing of genetic data

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The 23Andme, Inc. patent solves the following problem:

Recently, interest in genetics and genetic testing raised as to increase the amount of research on how genetic information of a human influence on a person's background, appearance, behavior, and physiology. Genetic information may be available to a person through the Internet. To prevent others from seeing the personal data, the individual is often required to login using a password to gain access to his data. In some cases, a person may want to share his personal information with one or more other people, such as family members. However, current techniques for sharing personal data on basic and had limited capabilities. Moreover, current techniques can be vulnerable to attack, possibly allowing personal data to be compromised. Thus, growth in the share of personal data that can be useful.

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 8589437 B1 deals with De-identification and sharing of genetic data.
A system for separate recognition of data from personal data exposed. system includes: a first set of stored data comprising a plurality of recognition data structures containing identifying data; a second set of stored data comprising a plurality of personal data structures containing personal data; a set of mapping data comprising a plurality of records, where each mapping is in the midst of a recognition framework data and a personal data structure; and an application configured to receive data mapping associated with a mapping, determine a mapping associated with the mapping data, and gain a personal structure that data base mapping. The set of data mapping is logically separate from the first set of stored data, the second set of stored data, and applications.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Multi compartment body part scraping fluid collection device

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Oasis Diagnostics Corp. patent solves the following problem:

Over the last few years there was a large increase in area of ​​salivary diagnostics, prompted in part by efforts from the National Institutes of Health (NIH) and the National Institute of Dental and Craniofacial Research (NIDCR) division to improve development of non-invasive technology for the diagnosis of disease and to measure specific analytes or molecules in saliva or oral fluid sample. These agencies make funds available for the development of novel, innovative tools including microarrays, lab-on-a-chip, lateral flow, ELISA and other technologies to use saliva and other non- invasive sampling method. Some reasons for the increased interest in salivary diagnostics involves the development of important new technologies for the collection and testing of oral fluids and improvements in the manufacturability of such devices.

Our analysis of this patent is as follows:

Oasis Diagnostics Corp.’s patent US 8551016 B2 deals with Multi compartment body part scraping fluid collection device.
A picture is a fluid sample collection system. More specifically, a picture is a fluid sample collection system to facilitate collection of biological specimens and especially to facilitate the collection of saliva, urine, and stool specimens from humans or animals for the purpose of obtaining pure DNA and / or RNA.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Gamete donor selection based on genetic calculations

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The 23Andme, Inc. patent solves the following problem:

Gamete storage facilities like a seed / egg bank making more people have greater control and more choice in reproduction. At present, some facilities in collecting the sperm or egg donation as well as certain profile information about the donors. Such information generally includes the donor race, height, weight, age, blood type, health condition, eye color, educational background, family history, and with a potential recipient can review the profile and make a choice. Although the personal profiles of donors can serve a useful purpose for the potential recipient to make a better choice, the information is usually offered only limited understanding for recipients with specific concerns about certain genetic traits, such as hereditary diseases, to make a truly informed choice. For example, a recipient of a family history of breast cancer may worry about receiving a donation from a man who was also a high risk group; however, if the family history information is incomplete or unavailable, have not been able to make an informed choice.

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 8543339 B2 deals with Gamete donor selection based on genetic calculations.
Gamete donor selection includes receiving a call including a phenotype of interest, accepting a genotype one receiving a plurality of genotypes in a respective plurality of donors, determine statistical information about the phenotype of interest based at least in part to different pairings genotype recipient and a genotype of a donor plurality of donors, and the recognition of a donor among the plurality of donors, based at least in part on statistical information determined.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Summarizing an aggregate contribution to a characteristic for an individual

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The 23Andme, Inc. patent solves the following problem:

Recently, interest in genetics and genetic testing raised as to increase the amount of research on how genetic information of a human influence on a person's background, appearance, behavior, and physiology. Genetic testing can provide information to help people understand the areas of potential concern to discuss with their doctors, and with a doctor, help individuals to make decisions about medical management and life-style choices. Typical genetic testing solutions allow a person to order a particular genetic test, such as type 2 diabetes. individual usually receives a summary report with a limited set of results with limited interpretative information. Progress interpretation and reporting of genetic test results useful.

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 8510057 B1 deals with Summarizing an aggregate contribution to a characteristic for an individual.
Summarized in an aggregate contribution to a characteristic of individual states, including to determine the nature of evaluating, identifying one or more points associated with nature, to recover measure the individual for each of the one or more points out of a database of individuals' points, taking a statistical thing to measure the association between the signs associated with nature and characteristics for each with one or more points from the database sign, and to determine the aggregate contributions based at least in part on the acquired statistical reasons.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Finding relatives in a database

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The 23Andme, Inc. patent solves the following problem:

Genealogy is the study of family history and lineage of ancestors. It is an interesting subject to study many professionals as well as hobbyists. Traditional techniques genealogical study often includes building family trees based on surnames and historical records. As gene sequencing technology becomes more accessible, there is growing interest in genetic ancestry testing in recent years.

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 8463554 B2 deals with Finding relatives in a database.
Determine relative relationship includes receiving recombinable deoxyribonucleic acid (DNA) information to a first user and recombinable DNA information to a second user, determining, based at least in part on information recombinable DNA for the first user and recombinable DNA information the second user, a foretold that kind of relationship between the first user and the second user, and the events that are expected to form the relationship between the first user and the second user at least meets the threshold door, letting in at least the first user of a family relationship with the second user.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Genotype calling

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The 23Andme, Inc. patent solves the following problem:

The instructions for making cells in the human body is encoded in deoxyribonucleic acid (DNA). DNA is a long, ladder-shaped molecule, each equivalent to climb up on a pair of interlocking units, called bases, appointed by the four letters of DNA AlphaBeta, T, G and C. a always pairs or chains with T, and G always pairs or chains with C. the order of these four letters in one DNA called human genome.

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 8428886 B2 deals with Genotype calling.
Determine a genetic sequence for a particular place in the genome of a man declared, including: receiving a measure associated with a particular file for the particular on the human genome, to receive contextual information associated with a context of individual within a larger collection of genetic information, and the use of measures associated with particular order -is and contextual information to calculate an improved determination of genetic sequences to particular parts of the human genome.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Polymorphisms associated with Parkinson’s disease

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The 23Andme, Inc. patent solves the following problem:

Parkinson's disease (PD) is a progressive degenerative disease of the central nervous system (CNS). PD is characterized by muscle rigidity, tremor, a slow physical movement (bradykinesia), impaired balance and coordination, and, in advanced stages, a loss of physical movement (akinesia). Over one million Americans suffer from Parkinson's disease, with prevalence of approximately 1 in 272 or 0.37% in the United States (US Census Bureau, Population Estimates, 2004).

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 8187811 B2 deals with Polymorphisms associated with Parkinson’s disease.
invention provides human polymorphisms associated with Parkinson's disease (PD). Also disclosed are compositions and methods for use in diagnostics, prognostics, prevention, treatment and / or study in PD.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.